One further comment on the UK's MNDA comments on DiPALS results . . . :

Their MNDA says the DPS harmed patients but the DiPALS writing committee report only says such patients might have been hurt AND their MNDA says the DPS ". . . was not beneficial . . ." whereas the DiPALS writing committee regarded the efficacy as 'low' rather than non-existent. Apparently the MNDA is not careful in its choice of words.